In CSCs, the elevated expression of CD36 was found and the uptake of an oxidized phospholipid, the ligand of CD36 drives glioma CSC proliferation, suggesting that the expression of CD36 is associated with CSC progression [30]. This evidence concerns the gene CD36 and central nervous system cancer.